PARP inhibitor
Rubraca Tablet (rucaparib) is a PARP inhibitor used for certain ovarian, fallopian tube, peritoneal, and prostate cancers. Learn uses, dosage, and side effects.
Lynparza Tablet (olaparib) treats BRCA-mutated or HRD-positive ovarian, breast, pancreatic, or prostate cancers. Learn uses, dosage, side effects, and warnings.
Zejula Capsule (niraparib) is a PARP inhibitor used as maintenance therapy for ovarian, fallopian tube, or peritoneal cancer. Learn dosage, side effects, and
Talzenna Capsule (talazoparib) is a PARP inhibitor for BRCA-mutated breast cancer and HRR-mutated prostate cancer. Learn uses, dosage, and side effects.
